Location: New York, NY
CIK: 0001534261 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value: $942M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BLUEPRINT MEDICINES CORP | 1,550,000 | $90.64M | 9.6% | $5615.52 | — | COM | 09627Y109 |
| SRPT | SAREPTA THERAPEUTICS INC | 670,000 | $65.54M | 7.0% | $121.78 | -6.1% | COM | 803607100 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 585,000 | $63.68M | 6.8% | $85.45 | +35.1% | COM | 02043Q107 |
| FATE | FATE THERAPEUTICS INC | 2,550,000 | $56.64M | 6.0% | $4.33 | +484.3% | COM | 31189P102 |
| CDXS | CODEXIS INC | 5,073,780 | $56.62M | 6.0% | $13.94 | +0.2% | COM | 192005106 |
| — | BLUEBIRD BIO INC | 1,105,000 | $50.79M | 5.4% | $21744.46 | — | COM | 09609G100 |
| — | INVITAE CORP | 3,478,388 | $47.55M | 5.0% | $10040.39 | — | COM | 46185L103 |
| — | MYOKARDIA INC | 995,000 | $46.65M | 5.0% | $39.07 | — | COM | 62857M105 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,070,000 | $37.96M | 4.0% | $50.94 | -9.3% | COM | 00847X104 |
| — | CONSTELLATION PHARMCETICLS I | 980,000 | $30.8M | 3.3% | $6.31 | — | COM | 210373106 |
| TWST | TWIST BIOSCIENCE CORP | 1,000,000 | $30.58M | 3.2% | $26.75 | +0.5% | COM | 90184D100 |
| RVMD | REVOLUTION MEDICINES INC | 1,319,536 | $28.91M | 3.1% | $27.68 | 0.0% | COM | 76155X100 |
| CDNA | CAREDX INC | 1,294,335 | $28.25M | 3.0% | $24.07 | -6.9% | COM | 14167L103 |
| ALEC | ALECTOR INC | 1,076,039 | $25.96M | 2.8% | $18.52 | +37.6% | COM | 014442107 |
| DNLI | DENALI THERAPEUTICS INC | 1,455,000 | $25.48M | 2.7% | $18.95 | +10.1% | COM | 24823R105 |
| BLFS | BIOLIFE SOLUTIONS INC | 2,468,571 | $23.45M | 2.5% | $15.40 | -10.8% | COM NEW | 09062W204 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | 793,125 | $22.03M | 2.3% | $37.47 | -25.6% | COM | 00650F109 |
| — | MAGENTA THERAPEUTICS INC | 2,971,034 | $18.66M | 2.0% | $1872.70 | — | COM | 55910K108 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 300,000 | $15.33M | 1.6% | $32.45 | — | COM | 37890U108 |
| FULC | FULCRUM THERAPEUTICS INC | 1,209,285 | $14.44M | 1.5% | $10.58 | +51.1% | COM | 359616109 |
| — | GENMARK DIAGNOSTICS INC | 3,365,000 | $13.86M | 1.5% | $6.69 | — | COM | 372309104 |
| — | GRITSTONE ONCOLOGY INC | 2,270,000 | $13.21M | 1.4% | $3195.68 | — | COM | 39868T105 |
| GILD | GILEAD SCIENCES INC | 175,000 | $13.08M | 1.4% | $54.92 | 0.0% | COM | 375558103 |
| CRSP | CRISPR THERAPEUTICS AG | 266,430 | $11.3M | 1.2% | $51.63 | 0.0% | NAMEN AKT | H17182108 |
| — | SAGE THERAPEUTICS INC | 385,000 | $11.06M | 1.2% | $65.16 | — | COM | 78667J108 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,125,000 | $10.99M | 1.2% | $9.77 | — | COM | 00773U108 |
| VYGR | VOYAGER THERAPEUTICS INC | 1,095,075 | $10.02M | 1.1% | $14.86 | — | COM | 92915B106 |
| ZLAB | ZAI LAB LTD | 190,000 | $9.781M | 1.0% | $51.48 | — | ADR | 98887Q104 |
| ALLO | ALLOGENE THERAPEUTICS INC | 500,000 | $9.72M | 1.0% | $23.82 | 0.0% | COM | 019770106 |
| — | BRISTOL-MYERS SQUIBB CO | 2,500,000 | $9.5M | 1.0% | $3.33 | — | RIGHT | 110122157 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,455,000 | $9.268M | 1.0% | $8.80 | -15.6% | COM | 800677106 |
| ILMN | ILLUMINA INC | 30,000 | $8.194M | 0.9% | $196.93 | +42.0% | COM | 452327109 |
| — | ORCHARD THERAPEUTICS PLC | 975,000 | $7.342M | 0.8% | $4002.03 | — | ADS | 68570P101 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 289,395 | $7.22M | 0.8% | $30.22 | 0.0% | COM | 09203E105 |
| — | DECIPHERA PHARMACEUTICALS IN | 140,000 | $5.764M | 0.6% | $13347.64 | — | COM | 24344T101 |
| DMTKQ | DERMTECH INC | 571,713 | $5.642M | 0.6% | $9.87 | — | COM | 24984K105 |
| — | TURNING POINT THERAPEUTICS I | 75,000 | $3.35M | 0.4% | $40080.00 | — | COM | 90041T108 |
| STOK | STOKE THERAPEUTICS INC | 120,000 | $2.748M | 0.3% | $27.21 | -9.2% | COM | 86150R107 |